An observational study in Tissue Adhesions, Cesarean Section, Repeat and Intra-abdominal Adhesions, sponsored by Ankara City Hospital Bilkent. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 46 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Ankara City Hospital Bilkent · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study evaluates how accurately a simple ultrasound test, the sliding sign, predicts intra-abdominal adhesions before a repeat cesarean delivery. Adhesions are bands of scar tissue that can form between the uterus, the bladder and the abdominal wall after a cesarean delivery. Adhesions can lengthen the next operation, delay delivery of the baby, increase bleeding and raise the risk of injury to the bladder or bowel.
The sliding sign is checked by placing a standard ultrasound probe on the abdomen while the woman breathes deeply. Free sliding of the uterus under the abdominal wall suggests that adhesions are unlikely; absence of sliding suggests that adhesions are present. The test takes 2 to 3 minutes, is painless, has no known risk to the mother or the baby, and adds no cost.
Pregnant women with at least one previous cesarean delivery who are scheduled for a planned repeat cesarean delivery at Ankara Bilkent City Hospital are invited to take part. The sliding sign is checked within 2 hours before surgery. During the operation, a surgeon who does not know the ultrasound result grades any adhesions on a standard four-grade scale, and the ultrasound result is compared with these surgical findings. The study also compares operative times, blood loss and complications between women with and without free sliding of the uterus, and examines whether the test performs differently after one previous cesarean delivery than after two or more. Taking part does not change the planned surgery or any other aspect of care.
Background:
Intra-abdominal adhesions are common after cesarean delivery, and their frequency and severity increase with each additional cesarean delivery. Adhesions prolong the interval from skin incision to delivery of the fetus and the total operative time, increase blood loss, and raise the risk of bladder and bowel injury. Preoperative prediction of the adhesion burden could support planning of the surgical team, estimation of operative time, blood preparation and patient counseling. The sliding sign is a simple transabdominal ultrasound test that shows whether the anterior uterine wall moves freely against the anterior abdominal wall during breathing. It requires no additional equipment or cost and takes 2 to 3 minutes. Its previously reported sensitivity is moderate (approximately 56%) and its specificity is high (approximately 95%). Test performance according to the number of previous cesarean deliveries, and the relationship between the test result and surgical outcomes, have not been well characterized.
Design:
Single-center, prospective, observational (non-interventional) diagnostic accuracy study at the Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, reported according to the STARD 2015 (Standards for Reporting of Diagnostic Accuracy Studies) guideline. Eligible women are invited consecutively.
Index test (sliding sign):
Within 2 hours before surgery, in the preoperative preparation room, transabdominal ultrasound is performed with a convex probe. Following the original technique, the movement of the anterior uterine wall relative to the anterior abdominal wall is observed while the participant breathes deeply, with the probe at the level of the umbilicus, lateral to the midsagittal plane. The suprapubic, right paramedian and left paramedian regions are also assessed separately, and the result for each region is recorded.
Reference standard (intraoperative adhesion grading):
Immediately after entry into the abdominal cavity and before any adhesiolysis, the operating surgeon grades adhesions on a four-grade cesarean-specific scale:
Blinding:
The ultrasound examiner is not the surgeon performing the operation. The operating surgeon is unaware of the ultrasound result, and the ultrasound examiner does not learn the surgical findings until the operation is completed. The ultrasound and surgical forms are completed separately, sealed in envelopes and matched at data entry.
Standardization and interobserver agreement:
Before the study begins, both assessors complete a standardization session on the technique and the grading definitions. In the first 30 participants, two investigators assess the sliding sign independently, within 15 minutes of each other.
Data collection:
Sociodemographic data, surgical history, operative times, blood loss, complications, laboratory values and newborn data are obtained from routine clinical care and from operative and anesthesia records. The only study-specific procedures are the 2-to-3-minute preoperative sliding sign assessment and the standardized recording of adhesions. Surgical technique, the decision for surgery, the timing of surgery and all other aspects of care are not changed by the study. Women whose operation becomes an emergency cesarean delivery after the ultrasound examination are excluded from the analysis and reported in the participant flow diagram. Participants may withdraw at any time without any effect on their care; on request, their data are removed from the analysis and destroyed.
Sample size:
Assuming a 30% prevalence of significant adhesions (Grade 2 or 3) and an expected sensitivity of 56%, 66 women with significant adhesions are required to estimate sensitivity with an absolute precision of ±12% (alpha 0.05), corresponding to 220 participants. This sample also provides more than the 73 women without significant adhesions required to estimate an expected specificity of 95% with a precision of ±5%. Allowing 10% for non-evaluable examinations and data loss, the target enrollment is 240 women, with 220 participants expected to be analyzable.
Statistical analysis:
121 studies on the registry are indexed under Tissue Adhesions; 15 are open to participants now.
This study's planned enrollment of 240 is above the median of 130 across 32 observational studies indexed under Tissue Adhesions.
Browse Tissue Adhesions studies →Ankara City Hospital Bilkent is the lead sponsor of 450 studies on the registry; 110 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pregnant women aged 18 to 45 years with at least one previous cesarean delivery who are scheduled for elective repeat cesarean delivery at 37 weeks of gestation or later at the Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, Ankara, Türkiye. Eligible women are invited consecutively during the study period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pregnant women with one previous cesarean delivery who are scheduled for elective repeat cesarean delivery at 37 weeks of gestation or later. All participants undergo a preoperative transabdominal ultrasound sliding sign assessment and intraoperative adhesion grading by a surgeon blinded to the ultrasound result. Surgical management is not changed by the study.
Diagnostic Test: Transabdominal Ultrasound Sliding Sign Assessment
Pregnant women with two or more previous cesarean deliveries who are scheduled for elective repeat cesarean delivery at 37 weeks of gestation or later. All participants undergo a preoperative transabdominal ultrasound sliding sign assessment and intraoperative adhesion grading by a surgeon blinded to the ultrasound result. Surgical management is not changed by the study.
Diagnostic Test: Transabdominal Ultrasound Sliding Sign Assessment
Transabdominal ultrasound examination with a convex probe, performed in the preoperative preparation room within 2 hours before surgery. Following the original technique, the movement of the anterior uterine wall relative to the anterior abdominal wall is observed while the participant breathes deeply, with the probe at the level of the umbilicus, lateral to the midsagittal plane. The suprapubic, right paramedian and left paramedian regions are also assessed separately. Absence of sliding in at least one assessed region is classified as a negative sliding sign (test positive, adhesions expected); sliding in all assessed regions is classified as a positive sliding sign (test negative). Examinations with inadequate image quality are classified as non-evaluable. The examination takes 2 to 3 minutes and does not change clinical management.
Also known as: Sliding sign, Uterine sliding sign
Sensitivity of the Sliding Sign for Significant Intra-Abdominal Adhesions
Proportion of participants with significant adhesions (Grade 2 or 3 on a four-grade intraoperative scale) who have a negative sliding sign (absence of sliding in at least one assessed region on preoperative transabdominal ultrasound). Adhesion grades: 0, none; 1, filmy adhesions separated by blunt dissection; 2, moderate or thick adhesions requiring sharp dissection; 3, dense, extensive adhesions with no free space between the uterus and the anterior abdominal wall. Adhesions are graded by the operating surgeon, blinded to the ultrasound result, immediately after entry into the abdominal cavity and before adhesiolysis. Reported as a percentage with 95% confidence interval (Wilson method), for all participants and for each group. Non-evaluable examinations are excluded from this analysis.
Time frame: Day of surgery: ultrasound within 2 hours before surgery; adhesion grading at entry into the abdominal cavity
Specificity of the Sliding Sign for Significant Intra-Abdominal Adhesions (Grade 2-3)
Proportion of participants without significant adhesions (Grade 0 or 1 on the four-grade intraoperative scale) who have a positive sliding sign (sliding in all assessed regions on preoperative transabdominal ultrasound). Adhesions are graded by the operating surgeon, blinded to the ultrasound result, immediately after entry into the abdominal cavity and before adhesiolysis. Reported as a percentage with 95% confidence interval (Wilson method), for all participants and for each group. Non-evaluable examinations are excluded from this analysis.
Time frame: Day of surgery: ultrasound within 2 hours before surgery; adhesion grading at entry into the abdominal cavity
Positive Predictive Value of the Sliding Sign for Significant Adhesions (Grade 2-3)
Proportion of participants with a negative sliding sign (absence of sliding in at least one assessed region) who have significant adhesions (Grade 2 or 3) at surgery. Reported as a percentage with 95% confidence interval (Wilson method), for all participants and for each group.
Time frame: Day of surgery: ultrasound within 2 hours before surgery; adhesion grading at entry into the abdominal cavity
Positive Likelihood Ratio of the Sliding Sign for Significant Adhesions (Grade 2-3)
Sensitivity divided by (1 minus specificity) of the sliding sign for significant adhesions (Grade 2 or 3) at surgery, reported with 95% confidence interval, for all participants and for each group.
Time frame: Day of surgery: ultrasound within 2 hours before surgery; adhesion grading at entry into the abdominal cavity
Plan to share: No — Individual participant data will not be shared, in accordance with the Turkish Personal Data Protection Law (Law No. 6698) and the scope of the informed consent approved by the ethics committee. Aggregate results will be reported in a peer-reviewed publication.
Start is estimated for Dec 2026; primary completion for Mar 2027, 3 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara City Hospital Bilkent →